# Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy

> **NCT00661011** · PHASE2 · TERMINATED · sponsor: **European Lung Cancer Working Party** · enrollment: 75 (actual)

## Conditions studied

- Non Small Cell Lung Carcinoma

## Interventions

- **PROCEDURE:** Lobectomy followed by concomitant mediastinal chemoradiotherapy

## Key facts

- **NCT ID:** NCT00661011
- **Lead sponsor:** European Lung Cancer Working Party
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** The study was terminated due to too slow recruitment
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661011, "Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00661011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*